mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
3e-07 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
3e-07 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
7e-07 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
7e-07 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
2e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
3e-06 |